Cell-free RNA Signatures Derived from the Tumor Microenvironment Predict Outcomes of CAR-T Therapy in Large B Cell Lymphoma
Loy, C. J.; Agun, G.; Maurer, K.; Vilaseca, A. B.; Potapova, D.; Jacobson, C.; Ritz, J.; De Vlaminck, I.
Show abstract
Anti-CD19 chimeric antigen receptor (CAR) T-cell therapy can induce durable remissions in patients with large B-cell lymphoma (LBCL), yet outcomes remain variable. Reliable pre-treatment predictors of durable response remain limited, leaving a critical gap in patient management. To address this, we profiled pre-treatment plasma cell-free RNA (cfRNA) from 91 LBCL patients treated with axicabtagene ciloleucel (axi-cel, Yescarta) across three independent cohorts. We first demonstrated that signatures of "lymph node-like" tumor microenvironments (TMEs), previously identified in tumor biopsies and shown to correlate with favorable outcomes, are specifically elevated in the pre-treatment plasma cfRNA of responders, but not in matched peripheral blood mononuclear cells (PBMCs). These observations indicate that cfRNA captures TME tissue-derived signals not reflected in circulating immune cells. Next, using unbiased approaches, we identified additional cfRNA signatures associated with one-year clinical outcomes that capture the underlying biological landscape of treatment response. Collectively, these findings support pre-treatment plasma cfRNA as a minimally invasive surrogate of TME state to prospectively inform durable CAR T-cell therapy outcomes and guide risk stratification and TME-modulating adjunct therapies.
Matching journals
The top 6 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Blood immunophenotyping identifies distinct kidney histopathology and outcomes in patients with lupus nephritis 94%
- Detection and monitoring of translocation renal cell carcinoma via plasma cell-free epigenomic profiling 94%
- Targeting EIF4A triggers an interferon response to synergize with chemotherapy and suppress triple-negative breast cancer 94%
Similar papers in this journal
- Elucidating the heterogeneity of immunotherapy response and immune-related toxicities by longitudinal ctDNA and immune cell compartment tracking in lung cancer 97%
- Myeloid cell-associated resistance to PD-1/PD-L1 blockade in urothelial cancer revealed through bulk and single-cell RNA sequencing 96%
- Single cell genomic characterization reveals the cellular reprogramming of the gastric tumor microenvironment 95%
Similar papers in this journal
- Distinct evolutionary paths in chronic lymphocytic leukemia during resistance to graft-versus-leukemia 98%
- Splicing modulators impair DNA damage response and induce killing of cohesin-mutant MDS/AML 94%
- RNA-seq of Human T-Cells After Hematopoietic Stem Cell Transplantation Identifies Linc00402 as a Novel Regulator of T-Cell Alloimmunity 94%
Similar papers in this journal
- Single cell view of tumor microenvironment gradients in pleural mesothelioma 95%
- Common trajectories of highly effective CD19-specific CAR T cells identified by endogenous T cell receptor lineages 95%
- Catalytic inhibition of KAT6/KAT7 enhances the efficacy and overcomes primary and acquired resistance to Menin inhibitors in MLL leukaemia 95%
Similar papers in this journal
- Pembrolizumab and Decitabine for Refractory or Relapsed Acute Myeloid Leukemia 96%
- Pooled screening for CAR function identifies novel IL13Rα2-targeted CARs for treatment of glioblastoma 95%
- KLRG1 marks tumor-infiltrating CD4 T cell subsets associated with tumor progression and immunotherapy response 95%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.